Skip to main content
Ortivus logo

Ortivus — Investor Relations & Filings

Ticker · ORTI ISIN · SE0000188930 LEI · 549300AVDV7UC14MTH79 ST Manufacturing
Filings indexed 511 across all filing types
Latest filing 2019-09-24 Regulatory Filings
Country SE Sweden
Listing ST ORTI

About Ortivus

https://www.ortivus.com/

Ortivus is a medical technology company that develops and supplies mobile solutions for prehospital and emergency medical care. The company's core product is MobiMed, an advanced electronic Patient Care Record (ePCR) system designed for paramedics and emergency medical services (EMS) providers. MobiMed facilitates real-time documentation and data sharing directly from the field. The platform integrates with a wide range of medical devices, such as patient monitors and defibrillators, as well as with hospital patient administration systems and national health registries. This ensures seamless information flow across the entire care pathway. Key functionalities include structured workflows, automated risk assessments, secure communication, and a web portal for real-time incident overviews. The system also supports telemedicine capabilities, including video consultations. By optimizing documentation and providing actionable insights, Ortivus solutions aim to improve patient safety, enhance care quality, and increase operational efficiency for healthcare organizations.

Recent filings

Filing Released Lang Actions
ORTIVUS HAS BEEN SELECTED AS PREFERRED BIDDER FOR PREHOSPITAL CARE BY THE SOUTH WESTERN AMBULANCE SERVICE TRUST (SWAST)
Regulatory Filings Classification · 95% confidence The document announces that Ortivus has been selected as the preferred bidder for a contract with the South Western Ambulance Service Trust (SWAST) valued at £8.5 M over five years. It details the scope of the contract (ePCR system implementation) and includes quotes from both companies. The final line states: "This information is information that Ortivus is obliged to make public pursuant to the EU Market Abuse Regulation." This strongly indicates a mandatory regulatory disclosure regarding a significant business event (a major contract award). Since this is a specific announcement of a business development that doesn't fit neatly into financial reports (10-K, IR, ER) or specific corporate actions (DIV, SHA, POS), the most appropriate general regulatory filing category is 'Regulatory Filings' (RNS), which serves as a catch-all for mandatory disclosures under market abuse regulations that aren't covered by other specific codes. The document length is moderate (4881 chars), but its primary function is the announcement itself, not the detailed report it might reference.
2019-09-24 English
ORTIVUS TILLDELAS ETT KONTRAKT OM £8,5 M GÄLLANDE LEVERANS AV AMBULANSJOURNAL TILL SOUTH WESTERN AMBULANCE TRUST (SWAST) I ENGLAND
Regulatory Filings Classification · 95% confidence The document is a press release written in Swedish announcing that Ortivus has been awarded an £8.5 million contract by the South Western Ambulance Service Trust (SWAST) in England for delivering ambulance journal software and services. The text details the contract value, duration, scope, and includes quotes from management. Crucially, the final lines state: "Denna information är sådan information som Ortivus är skyldigt att offentliggöra enligt EU:s marknadsmissbruksförordning. Informationen lämnades, genom ovanstående kontaktpersons försorg, för offentliggörande den 2019-09-24 09:50 CEST." This structure strongly indicates a regulatory disclosure regarding a significant event (a major contract win). Since it is not a full financial report (10-K, IR), an earnings release (ER), or a specific management/board change (MANG), it falls best under the general category for regulatory announcements that disclose material information, which is 'Regulatory Filings' (RNS). It is not a proxy statement (DEF 14A/PSI) or a capital change (CAP/SHA/POS).
2019-09-24 Swedish
Major Shareholding Notification 2019
Major Shareholding Notification Classification · 99% confidence The document details changes in shareholding percentages and voting rights for a specific holder (Nordnet AB (publ)) in the issuer (Ortivus Aktiebolag). It explicitly mentions 'Reason for major shareholding notification' and shows 'Before the transaction' and 'After the transaction' figures, including the percentage crossing a threshold (5%). This structure is characteristic of a Major Shareholding Notification, which corresponds to the filing type code MRQ (Major Shareholding Notification). The document is a direct notification, not an announcement of a report.
2019-09-06 English
Major Shareholding Notification 2019
Major Shareholding Notification Classification · 99% confidence The document details a change in shareholding and voting rights for a specific instrument (Aktier SE0000123085) held by Nordnet AB (publ) in Ortivus Aktiebolag. It explicitly mentions 'Reason for major shareholding notification' and shows the 'Before' and 'After the transaction' distribution, including percentages of voting rights (e.g., crossing the 5% threshold). This structure is characteristic of a Major Shareholding Notification, which corresponds to the filing type code MRQ (Major Shareholding Notification). The document is a direct report of the change, not an announcement of a report.
2019-09-03 English
Interim / Quarterly Report 2019
Interim / Quarterly Report Classification · 100% confidence The document is a 'Delårsrapport' (Interim Report) for the period January to June 2019 for the company Ortivus. It contains comprehensive financial statements, including income statements, balance sheets, cash flow analysis, and management commentary on business performance and outlook. It is not a mere announcement or certification, but the full interim financial report itself. H1 2019
2019-08-22 Swedish
Ortivus agreement with Northern Ireland Ambulance Service HSC Trust on ambulance records now signed
Regulatory Filings Classification · 100% confidence The document announces the signing of an agreement between Ortivus and the Northern Ireland Ambulance Service (NIAS) regarding the delivery of the MobiMed system. It details the contract value (GBP 2.7 million) and implementation timeline. The text concludes with a statement: "This information is information that Ortivus is obliged to make public pursuant to the EU Market Abuse Regulation." This strongly suggests a mandatory regulatory disclosure concerning a significant business event (a contract award/signing). Since this is a specific announcement about a business development (a contract) and not a general financial report (10-K, IR, ER), it fits best under the general regulatory announcement category, which is RNS (Regulatory Filings), as it doesn't fit the more specific categories like M&A (TAR), Financing (CAP), or Director Dealing (DIRS). Given the context of mandatory disclosure under EU Market Abuse Regulation, RNS is the most appropriate general regulatory filing code.
2019-08-12 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.